SLYVIA ESTRADA: Open Payments
NPI 1619101516 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 11 payments from 8 companies in 2025. Trend: 2023 $122 · 2024 $488 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $235 |
| Syndax Pharmaceuticals, Inc. | 2 | $226 |
| PFIZER INC. | 2 | $164 |
| Gilead Sciences, Inc. | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $122 |
| Daiichi Sankyo Inc. | 1 | $51 |
| Merck Sharp & Dohme LLC | 1 | $38 |
Products named: OPDIVO, Orserdu, REVUFORJ, DATROWAY, ADCETRIS, IBRANCE, Enhertu, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
